Posts tagged with Techno-Derm

Techno-Derm, LLC Announces the Exclusive Distribution Agreement for NARL, a New Line of Professional Ultrasound Lipolysis Beauty Products.

August 13th, 2009

Techno-Derm, LLC has just announced an exclusive agreement to market and distribute NH LIMITED’s NARL line of ultrasound lipolysis beauty products in the Americas. NARL products offer a breakthrough solution for professional spas and medi-spas to prevent and treat fat-related disorders, bringing long-lasting solutions for slimming, health, wellness and beauty to millions.

NARL’s patented, non-invasive beauty products are designed to reduce fat (subcutaneous and visceral fat) and diminish cellulite.  NARL is an abbreviation for ‘noradrenaline release.’ It’s thus named because NARL medical devices use a very safe level of ultrasound frequency and intensity (517 KHz – 110 mW/cm2) to naturally activate the release of noradrenaline (a type of nerve or stress hormone called a ‘catecholamine’ that acts like a neurotransmitter by signaling the release of glucose energy stores).  When released from nerves, noradrenaline triggers natural fat cell lipolysis, or fat breakdown.  As the resulting fatty acids and glycerol are released into the body, they’re burned off as energy.  And since NARL’s localized stimulation is uniquely able to bypass the central nervous system, fat is more likely to stay off – permanently.

This addition to Techno-Derm’s professional product portfolio complements the existing line of non-invasive fat, lipolysis and cellulite products.  Although in Techno-Derm’s official launch of NARL products is pending FDA clearance in the US, NARL products are aggressively being marketed to South and Central America.

Says Techno-Derm CEO Michel Van Welden, “There is a great need in countries like Brazil, Mexico and Venezuela for affordable fat and cellulite reduction technologies like NARL. As the first lipolysis ultrasound product of its kind, NARL has the potential to completely revolutionize the spa and medi-spa market in South America.” And of the pending FDA clearance, Van Welden says, “NARL treatments and technologies are supported by more than 7 years of clinical studies proving their safety and efficacy. No side effects have been reported.  We expect to receive FDA clearance very soon.”

About Techno-Derm
Techno-Derm will market and distribute NARL in the Americas (Antigua, Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Canada, Chile, Columbia, Costa Rica, Cuba,Dominica, Dominican Republic, Ecuador, El Salador, Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Kitts, Nevis, Saint Lucia, Saint Vincent, Grenadines, Suriname, Trinidad, Tobago, United States, Uruguay and Venezuela) by Techno-Derm, LLC, 1071 NE 79th Street, Ste. 101 in Miami, Florida. Techno-Derm is an independently owned and operated distributorship of industry-leading beauty, health, wellness and sport technologies and supplies. For more on NARL medical devices, please email [email protected]. For media inquiries, please contact Rebecca Hausen of ReVcom Group at 305-335-8696 or by email [email protected].

Techno-Derm Goes ‘Green’ with Renaissance Body Gloves, Giving America’s Hottest Spas Eco-Friendly Exfoliation

April 3rd, 2009

Miami, FL March 29, 2009: Techno-Derm is now distributing Renaissance® Body Gloves, natural anti-aging exfoliates that strip away residues, toxins and dead skin cells – without stripping away the environment.

Renaissance Body Gloves are composed of environmentally friendly, biodegradable vegetal cellulose obtained from eucalyptus and spruce. The exclusive fabric has thousands of microscopic loops that are specially designed to deeply exfoliate without irritating or over drying skin. The fine, natural fibers are gentle enough for every day use on the whole body.

Renaissance Body Gloves deep-clean to eliminate dead skin cells, soap scum and other pore-clogging, grimy residues for super soft, silky-smooth skin. Fighting ingrown hairs and preventing acne breakouts, this hardworking body buffer simultaneously boosts skin’s receptivity to topical skincare treatments (i.e. self-tanning, slimming, and moisturizing products), thereby increasing their efficacy. Besides providing an incredible sensorial massage, Renaissance Body Gloves’ intensive exfoliation stimulates microcirculation and eliminates cellulite-forming toxins. The vigorous action also oxygenates the epidermis for accelerated cell renewal and healthy skin regrowth. That means it visibly improves sun-damaged skin marked by age spots and fine lines.

Renaissance Body Gloves lather well to conserve cleansing products. They’re easy to care for (machine washable; fast drying) and offer long-lasting durability. Perfect for all bathrooms and travel bags, Renaissance body gloves are hand-dyed in four attractive colors: green, blue, red and terra cotta. They retail for $22.50 apiece and are available for resale in spas and medi-spas.

Renaissance body gloves are marketed and distributed by Techno-Derm, LLC, 10800 Biscayne Blvd., Ste. 850 in Miami, Florida. Techno-Derm is an independently owned and operated distributorship of industry-leading beauty, health, wellness and sport technologies, skincare and supplies. For more on Renaissance exfoliating gloves, visit http://www.dermxpert.com/gant_renaissance.php. For media inquiries, contact Rebecca Hausen of ReVcom Group at 305-335-8696 or [email protected]

Techno-Derm Debuts Clayton Shagal’s Collagen – The First 99% Pure, Professional-Grade Collagen Formulation With 100% Efficacy.

February 26th, 2009

Miami, FL Techno-Derm announced today that it’s distributing Clayton Shagal’s Collagen, the first 99% pure, professional-grade collagen formulation on the market able to penetrate protective skin barriers and restore collagen fibrils with 100% efficacy.

Comprising about 90% of connective tissue, collagen is the foundation of skin. It holds the face together. But with age, the body stops producing the collagen fibrils. Collagen depletion is the primary reason for skin aging. A dull complexion, fine lines, wrinkles and loose, sagging skin may all be attributed to collagen loss. To illustrate, imagine a beautiful building with an eroding foundation. Over time, that building façade will crumble beyond recognition. In a similar way, facial features deteriorate with depleted collagen stores. That’s where Clayton Shagal’s Collagen extract and gel come in: they implant macromolecular collagen fibrils deep within the connective tissue (dermis layer) to increase the volume of existing collagen for stronger, healthier and younger-looking skin.

Clayton Shagal’s Collagen uses an exclusive, non-hydrolyzed acid-soluble collagen. It’s obtained with a patented extraction process that allows it to maintain the same molecular shape of the natural collagen in human skin. That means the active ingredients in Clayton Shagal’s Collagen products are uniquely able to penetrate both the epidermis and dermis skin layers – and to do so without compromising their molecular structure. So unlike other skincare products, Clayton Shagal’s Collagen doesn’t lose efficacy when penetrating protective skin barriers. It’s 100% potent when it reaches the collagen fibrils. The fast, concentrated absorption the results means that Clayton Shagal Collagen delivers incredible anti-aging results – instantly!

Clayton Shagal Collagen is marketed and distributed by Techno-Derm, LLC, 10800 Biscayne Blvd., Ste. 850 in Miami, Florida on a consignment basis (in effect, this means medi-spas are only charged for what they sell). Techno-Derm is an independently owned and operated distributorship of industry-leading beauty, health, wellness and sport technologies, skincare and supplies. For more on Clayton Shagal Collagen anti-aging skincare, visit www.claytonshagal.com. For media inquiries, please contact Rebecca Hausen of ReVcom Group at 305-335-8696 or by email [email protected].

Techno-Derm Launches Veinwave: A New, FDA Listed Medical Device for Eliminating Thread Veins

February 22nd, 2009

Miami, FLMillions of men and women suffer from thread veins, manifest by unsightly little clusters of red, blue or purplish veins that spiderweb the cheeks, thighs, calves, ankles and knees. In fact, for Western populations like the US, it’s been estimated[1] that 25-30% of women and 10-20% of men suffer from this unsightly condition. But now there’s a thread of hope. Adding to its full suite of medical technologies, Techno-Derm, LLC, announced its exclusive distribution of Veinwave, a new, FDA listed device for eliminating thread veins, telangiectasia, psoriasis and rosacea.

Designed primarily for vascular surgeons and dematologists, Veinwave uses a revolutionary process called ‘thermo-coagulation.’ As tiny, extremely high frequency microwaves are applied to the affected skin, the inflamed thread vessels are heated. When this happens, veins do a disappearing act.

Until now, micro-sclerotherapy and lasers have been the most popular procedures for removing these veins. Unlike lasers, the Veinwave procedure isn’t painful, doesn’t carry a risk of long-term scarring and is over in 15 minutes. How is this possible? Veinwave’s ultra-fine, insulated needle makes for a highly targeted treatment that doesn’t irritate the surrounding skin tissue. That means there’s no bandages or recovery time. Within 15 minutes after a Veinwave session, patients can resume their everyday activities as if it never happened. As for micro-sclerotherapy, it works pretty well on the larger varicose leg veins, but it’s not too effective on the fine, thin veins of delicate facial, knee and ankle areas. But when paired with Veinwave, micro-sclerotherapy works perfectly.

Contact Information:

Veinwave is marketed and distributed in the US by Techno-Derm, LLC, 10800 Biscayne Blvd., Ste. 850 in Miami, Florida. Techno-Derm is an independently owned and operated distributorship of industry-leading beauty, health, wellness and sport technologies and supplies. For more on Veinwave medical devices, visit www.veinwave.us. For media inquiries, please contact Rebecca Hausen of ReVcom Group at 305-335-8696 or by email [email protected].


[1] Evans CJ, Fowkes FG, Ruckley CV, et al. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population. J Epidemiol Community Health 1999;53:149–153.

LPG’s Cellu M6 Keymodule Gets FDA Clearance for Treating Lymphedema

December 17th, 2008

Miami, FL – According to the World Health Organization, Lymphedema afflicts hundreds of millions worldwide. Of these, the US Department of Health and Human Services estimates more than 300 million are American. Various forms of massage are used to treat this painful condition, but none really have enough consistency or depth-of-action to produce results. But now one does. The Food and Drug Administration (FDA), has just given the Class 1 Cellu M6 Keymodule, manufactured by LPG, Inc. (a medical device company renowned as the world leader in connective tissue technology), full FDA clearance for Lymphedema. The new claims are as follows:

· Reduction of secondary Lymphedema of the arm (SLA) post mastectomy (RX only)

· Improvement of secondary Lymphedema (RX only)

· Improvement of lymphatic circulation in the treated area (RX only)

For this FDA clearance, LPG presented well-documented, scientifically proven clinical results showing the Technology’s efficacy on the body’s circulatory, anti-edematous and dermatrophic systems. Along with these published studies, multimodal clinical studies examining the efficacy and durability of the traditional Manual Lymphatic Drainage (MLD) and Compression Bandaging (CB) versus the non-invasive LPG Treatment were conducted by Neil Piller, M.D., Professor for Lymphology at the Lymphedema Assessment Clinic of Flinders University Medical Center in South Australia.

Michel Van Welden, the Chief Executive Officer of Techno-Derm (LPG’s exclusive US distributor), explains, “Dr. Piller’s research demonstrates that LPG Technology offers an all-inclusive, standardized therapy for SLA pathology – with greater consistency, efficacy and faster results than MLD – which confirms that LPG devices are essential for treating patients with Lymphedema.”

The study included 45 patients with a Lymphedema volume difference of > 200 ML who had had a mastectomy and auxiliary clearance with SLA within at least 31 mo. (post-chemo and/or radiotherapy). The 24 in the LPG test group completed 16 sessions for anastomosis mobilization and drainage (4 times a week over 4 weeks) for 25 minutes (duration/session). The 21 in the MLD Control Group completed 16 sessions on the unaffected and affected arms, neck, back, upper am and torso (4 times a week over 4 weeks) for 45 minutes (duration/session).

Participants were required to have not had active arm or LPG Treatment prior to entry. Evaluation criteria included perometry imaging device for volume and cutaneous skinfold circumference measurements, tonometry for bio-impedance measurements, lymphoscintigraphy for functional modifications, echography for tissue thickness and structural modifications and self questionnaires of QDV impact on pain, hardness, and heaviness.

The research concluded that the LPG Treatment showed significant decreases in perometry (18%), bio-impedance (23.5%), and tissue softening in half the time as the MLD control group and with a sustained effect. What’s that mean? That LPG’s FDA cleared Cellu M6 Keymodule presents a lastingly effective solution for millions of Lymphedema sufferers around the world. Lymphedema occurs whenever lymph nodes have been damaged – so although this study examines the Cellu M6 Keymodule’s treatment of breast cancer mastectomy Lymphedema – it’s also ideal for Lymphedemas resulting from lumpectomies, radiation treatments and many other procedures.

Study Information:

Professor Neil Piller, MD is a lymphologist and the Team Leader of the Lymphedema Assessment Clinic at Flinders Surgical Oncology. He is a professor at the Flinders University Medical Center in South Australia and co-author of The Lymphedema Handbook: Causes, Effects and Management, 2002.

Company Information:

LPG Technology is marketed and distributed by Techno-Derm, LLC, (DBA: LPG America), 10800 Biscayne Blvd., Ste. 850 in Miami, Florida. For more on LPG treatments and LPG’s FDA-cleared medical devices, visit www.cellum6.com.

Contact Information:

To view a copy of Piller’s study, learn more about LPG’s FDA Lymphedema claims or schedule an interview with a Company representative, please contact Rebecca Hausen at 305-335-8696 or by email [email protected].